Novartis Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Novartis AG ADR
NVS Stock  USD 112.22  3.16  2.90%   
Novartis financial statements provide useful quarterly and yearly information to potential Novartis AG ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Novartis financial statements helps investors assess Novartis' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Novartis' valuation are summarized below:
Gross Profit
38.9 B
Profit Margin
0.2309
Market Capitalization
215.6 B
Enterprise Value Revenue
4.514
Revenue
51.7 B
There are over one hundred nineteen available fundamental ratios for Novartis, which can be analyzed over time and compared to other ratios. All traders should check Novartis' last-minute fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 111.1 B in 2025. Enterprise Value is likely to drop to about 117.3 B in 2025

Novartis Total Revenue

46.55 Billion

Check Novartis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novartis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 571.2 M or Selling General Administrative of 7.3 B, as well as many indicators such as Price To Sales Ratio of 2.76, Dividend Yield of 0.0247 or PTB Ratio of 2.35. Novartis financial statements analysis is a perfect complement when working with Novartis Valuation or Volatility modules.
  
Check out the analysis of Novartis Correlation against competitors.

Novartis Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets103.5 B102.2 B117.5 B
Pretty Stable
Short and Long Term Debt Total19.2 B31.3 B24.6 B
Slightly volatile
Other Current Liabilities11.2 B13.4 B12.8 B
Slightly volatile
Total Current Liabilities22.4 B28.7 B25.5 B
Slightly volatile
Total Stockholder Equity56.8 B44 B62.1 B
Pretty Stable
Property Plant And Equipment Net13.4 B10.9 B14.2 B
Slightly volatile
Net Debt11.4 B19.8 B15.8 B
Slightly volatile
Retained Earnings58 B57.1 B65 B
Very volatile
Accounts Payable4.2 B4.6 B5 B
Pretty Stable
Cash7.9 B11.5 B8.8 B
Slightly volatile
Non Current Assets Total73.5 B72.5 B87.1 B
Very volatile
Cash And Short Term Investments13.1 B13.4 B12.2 B
Slightly volatile
Net Receivables8.9 B9.5 B9.2 B
Very volatile
Common Stock Total Equity776.8 M821.7 M945.6 M
Slightly volatile
Common Stock Shares Outstanding1.9 B2 B2.3 B
Slightly volatile
Short Term Investments1.8 B1.9 B3.2 B
Pretty Stable
Liabilities And Stockholders Equity103.5 B102.2 B117.5 B
Pretty Stable
Non Current Liabilities Total23.9 B29.4 B29.7 B
Slightly volatile
Inventory6 B5.7 B6.4 B
Pretty Stable
Other Current Assets1 B1.1 B2.1 B
Pretty Stable
Total Liabilities46.3 B58.1 B55.2 B
Slightly volatile
Property Plant And Equipment Gross14.4 B22 B15.7 B
Slightly volatile
Total Current Assets30 B29.7 B30.3 B
Slightly volatile
Capital Stock762.7 M793 M935.3 M
Slightly volatile
Short Term Debt6.4 B8.3 B6.7 B
Slightly volatile
Common Stock762.7 M793 M935.3 M
Slightly volatile
Intangible Assets22.7 B26.9 B28.6 B
Pretty Stable
Other Liabilities8.5 B8.7 B10 B
Pretty Stable
Other Assets10.1 B5.6 B10.8 B
Very volatile
Long Term Debt13.3 B21.4 B17.3 B
Slightly volatile
Good Will22.2 B24.8 B27.4 B
Pretty Stable
Property Plant Equipment14 B14 B14.3 B
Very volatile
Noncontrolling Interest In Consolidated Entity93.5 M95.5 M92.2 M
Pretty Stable
Deferred Long Term Liabilities5.8 B5.1 B4.6 B
Slightly volatile
Long Term Investments1.1 B1.1 B8.9 B
Slightly volatile
Short and Long Term Debt5.7 B8.1 B9.1 B
Slightly volatile
Long Term Debt Total24.2 B25 B20.6 B
Slightly volatile
Non Current Liabilities Other1.1 B1 B1.4 B
Slightly volatile
Cash And Equivalents7.6 B5.3 B6 B
Slightly volatile
Net Invested Capital71.5 B73.5 B94.1 B
Slightly volatile
Capital Lease Obligations1.5 B1.8 B1.9 B
Slightly volatile

Novartis Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.2 B6.1 B3.9 B
Pretty Stable
Selling General Administrative7.3 B12.6 B8 B
Slightly volatile
Selling And Marketing Expenses12.8 B14.8 B12.8 B
Pretty Stable
Total Revenue46.5 B51.7 B50.2 B
Very volatile
Gross Profit32.6 B38.9 B34.4 B
Pretty Stable
Other Operating Expenses37.1 B37.2 B40.4 B
Very volatile
Operating Income10.1 B14.5 B10.9 B
Slightly volatile
EBIT11.1 B14.6 B12.2 B
Pretty Stable
Research Development8 B10 B9 B
Slightly volatile
EBITDA14.3 B20.7 B16.1 B
Slightly volatile
Cost Of Revenue13.9 B12.8 B15.8 B
Pretty Stable
Total Operating Expenses23.2 B24.4 B24.6 B
Pretty Stable
Income Before Tax10.4 B13.6 B11 B
Pretty Stable
Net Income9.8 B11.9 B10.6 B
Slightly volatile
Income Tax Expense1.5 B1.7 B1.4 B
Very volatile
Net Income Applicable To Common Shares9.8 B8 B10.2 B
Pretty Stable
Net Income From Continuing Ops11 B11.9 B10 B
Pretty Stable
Tax Provision1.7 B1.7 B1.4 B
Slightly volatile
Interest Income539.6 M568 M1.3 B
Pretty Stable
Reconciled Depreciation7.4 B6.1 B6.5 B
Slightly volatile

Novartis Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow9.3 B13.8 B10.2 B
Slightly volatile
Begin Period Cash Flow7.6 B13.4 B8.5 B
Slightly volatile
Depreciation4.3 B6.1 B5.6 B
Slightly volatile
Capital Expenditures2.7 B3.8 B2.9 B
Pretty Stable
Total Cash From Operating Activities12 B17.6 B13.2 B
Slightly volatile
Net Income8.9 B11.9 B9.6 B
Slightly volatile
End Period Cash Flow7.9 B11.5 B8.8 B
Slightly volatile
Dividends Paid5.2 B7.6 B6.3 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.763.79923.5535
Pretty Stable
Dividend Yield0.02470.03880.0353
Very volatile
PTB Ratio2.354.46133.0156
Slightly volatile
Days Sales Outstanding80.8567.316372.6487
Very volatile
Book Value Per Share17.8221.931426.3871
Very volatile
Free Cash Flow Yield0.0480.07030.058
Very volatile
Operating Cash Flow Per Share9.198.7575.9956
Slightly volatile
Average Payables942 M1.1 B1.2 B
Slightly volatile
Stock Based Compensation To Revenue0.01150.02020.0145
Slightly volatile
Capex To Depreciation0.880.62840.583
Slightly volatile
PB Ratio2.354.46133.0156
Slightly volatile
EV To Sales2.924.1823.8562
Slightly volatile
Free Cash Flow Per Share7.26.86134.6732
Slightly volatile
ROIC0.110.15550.0989
Slightly volatile
Inventory Turnover1.822.24132.4383
Slightly volatile
Net Income Per Share3.065.93494.5474
Slightly volatile
Days Of Inventory On Hand184163154
Pretty Stable
Payables Turnover3.982.80563.377
Slightly volatile
Sales General And Administrative To Revenue0.05460.0490.0471
Slightly volatile
Average Inventory3.7 B4.1 B4.5 B
Slightly volatile
Research And Ddevelopement To Revenue0.140.19380.1757
Slightly volatile
Capex To Revenue0.04460.07370.0572
Very volatile
Cash Per Share4.096.63575.2359
Slightly volatile
POCF Ratio15.2911.152914.15
Pretty Stable
Interest Coverage20.4414.457315.023
Very volatile
Payout Ratio0.420.63850.646
Pretty Stable
Capex To Operating Cash Flow0.240.21650.2269
Slightly volatile
PFCF Ratio19.7614.234218.4151
Pretty Stable
Days Payables Outstanding84.9130113
Slightly volatile
Income Quality1.111.47581.4683
Very volatile
ROE0.140.27110.1743
Slightly volatile
EV To Operating Cash Flow16.1412.276715.3102
Very volatile
PE Ratio14.2616.456218.7857
Very volatile
Return On Tangible Assets0.130.23610.1688
Slightly volatile
EV To Free Cash Flow20.8515.668419.9091
Pretty Stable
Earnings Yield0.05020.06080.0594
Very volatile
Intangibles To Total Assets0.270.50540.4443
Pretty Stable
Net Debt To EBITDA0.50.95580.9218
Pretty Stable
Current Ratio1.671.03531.2411
Very volatile
Receivables Turnover5.535.42225.1288
Pretty Stable
Graham Number34.3254.067650.7678
Pretty Stable
Shareholders Equity Per Share17.721.891726.3422
Very volatile
Debt To Equity0.750.70970.4344
Slightly volatile
Capex Per Share1.991.89561.3223
Slightly volatile
Average Receivables3.5 B3.9 B4.2 B
Slightly volatile
Revenue Per Share14.5425.706821.405
Pretty Stable
Interest Debt Per Share16.8416.035811.618
Slightly volatile
Debt To Assets0.320.30570.2171
Slightly volatile
Enterprise Value Over EBITDA13.3810.441812.1297
Very volatile
Short Term Coverage Ratios1.542.17811.991
Pretty Stable
Price Earnings Ratio14.2616.456218.7857
Very volatile
Operating Cycle265230227
Pretty Stable
Price Book Value Ratio2.354.46133.0156
Slightly volatile
Days Of Payables Outstanding84.9130113
Slightly volatile
Dividend Payout Ratio0.420.63850.646
Pretty Stable
Price To Operating Cash Flows Ratio15.2911.152914.15
Pretty Stable
Price To Free Cash Flows Ratio19.7614.234218.4151
Pretty Stable
Pretax Profit Margin0.250.26370.2216
Pretty Stable
Ebt Per Ebit1.160.93781.0367
Very volatile
Operating Profit Margin0.180.28120.2143
Pretty Stable
Effective Tax Rate0.170.12470.1427
Slightly volatile
Company Equity Multiplier1.442.32131.8893
Slightly volatile
Long Term Debt To Capitalization0.340.32660.2244
Slightly volatile
Total Debt To Capitalization0.440.41510.2951
Slightly volatile
Return On Capital Employed0.140.19770.1241
Pretty Stable
Debt Equity Ratio0.750.70970.4344
Slightly volatile
Ebit Per Revenue0.180.28120.2143
Pretty Stable
Quick Ratio1.350.83580.9777
Very volatile
Dividend Paid And Capex Coverage Ratio1.941.54041.6035
Slightly volatile
Net Income Per E B T0.750.87540.9704
Very volatile
Cash Ratio0.430.39940.3526
Slightly volatile
Cash Conversion Cycle149100112
Pretty Stable
Operating Cash Flow Sales Ratio0.20.34060.2568
Slightly volatile
Days Of Inventory Outstanding184163154
Pretty Stable
Days Of Sales Outstanding80.8567.316372.6487
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.620.78350.7643
Very volatile
Cash Flow Coverage Ratios0.870.56370.5774
Pretty Stable
Price To Book Ratio2.354.46133.0156
Slightly volatile
Fixed Asset Turnover2.794.75693.5345
Slightly volatile
Capital Expenditure Coverage Ratio3.724.61964.5347
Pretty Stable
Price Cash Flow Ratio15.2911.152914.15
Pretty Stable
Enterprise Value Multiple13.3810.441812.1297
Very volatile
Debt Ratio0.320.30570.2171
Slightly volatile
Cash Flow To Debt Ratio0.870.56370.5774
Pretty Stable
Price Sales Ratio2.763.79923.5535
Pretty Stable
Return On Assets0.110.11680.0927
Slightly volatile
Asset Turnover0.520.50590.4415
Pretty Stable
Net Profit Margin0.170.23090.209
Pretty Stable
Gross Profit Margin0.780.7520.6912
Slightly volatile
Price Fair Value2.354.46133.0156
Slightly volatile
Return On Equity0.140.27110.1743
Slightly volatile

Novartis Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap111.1 B196.5 B173.5 B
Slightly volatile
Enterprise Value117.3 B216.3 B188.3 B
Slightly volatile

Novartis Fundamental Market Drivers

Forward Price Earnings13.3511
Cash And Short Term Investments13.4 B

Novartis Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Novartis Financial Statements

Novartis shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Novartis investors may analyze each financial statement separately, they are all interrelated. The changes in Novartis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Novartis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue127 M136 M
Total Revenue51.7 B46.5 B
Cost Of Revenue12.8 B13.9 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.05  0.05 
Research And Ddevelopement To Revenue 0.19  0.14 
Capex To Revenue 0.07  0.04 
Revenue Per Share 25.71  14.54 
Ebit Per Revenue 0.28  0.18 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY